Posts

Nursing Paper Example on Cushing’s Syndrome

Nursing Paper Example on Cushing’s Syndrome

Cushing’s syndrome is a rare endocrine disorder caused by prolonged exposure to high levels of cortisol. It can result from endogenous overproduction or exogenous corticosteroid use. The condition leads to a wide array of systemic manifestations, significantly impacting a patient’s physical and metabolic health. Early diagnosis and appropriate treatment are crucial to prevent severe complications.


Nursing Paper Example on Cushing's Syndrome

Causes of Cushing’s Syndrome

Cushing’s syndrome can result from endogenous or exogenous factors.

Exogenous Causes

Chronic corticosteroid therapy: Often prescribed for conditions like asthma, rheumatoid arthritis, or organ transplant.

Topical or inhaled corticosteroids: When used excessively over long periods.

Endogenous Causes

  • Adrenocorticotropic hormone (ACTH)-dependent:

Pituitary adenomas (Cushing’s disease): Most common endogenous cause.

Ectopic ACTH production: Seen in small cell lung cancer and other tumors.

  • ACTH-independent:

Adrenal adenomas or carcinomas: Lead to excessive cortisol production.

Macronodular adrenal hyperplasia: Rare cause of cortisol overproduction.


Signs and Symptoms

Cushing’s syndrome presents with a spectrum of clinical features, many of which are due to hypercortisolism’s catabolic effects.

Physical Features

  • Central obesity with thin extremities.
  • Moon facies (round, puffy face).
  • Dorsocervical fat pad (buffalo hump).
  • Purple striae on the abdomen, thighs, and breasts.
  • Easy bruising and delayed wound healing.

Systemic Symptoms

Musculoskeletal: Proximal muscle weakness, osteoporosis, and fractures.

Metabolic: Hyperglycemia, insulin resistance, and dyslipidemia.

Cardiovascular: Hypertension, increased risk of thromboembolism.

Neuropsychiatric: Mood swings, depression, anxiety, or psychosis.

Reproductive: Irregular menstruation, infertility, or decreased libido.


Etiology

The etiology of Cushing’s syndrome varies depending on its endogenous or exogenous origin.

Pituitary Tumors (Cushing’s Disease)

ACTH-secreting pituitary adenomas are the most common endogenous cause.

Ectopic ACTH Production

Neuroendocrine tumors (e.g., small cell lung cancer, thymic tumors) produce ACTH aberrantly.

Adrenal Causes

Adenomas, carcinomas, or hyperplasia can independently produce excessive cortisol.

Iatrogenic Causes

Prolonged corticosteroid use for chronic inflammatory or autoimmune conditions is the leading cause of exogenous Cushing’s syndrome.


Pathophysiology

Cushing’s syndrome results from sustained hypercortisolism, disrupting various physiological processes.

Mechanism of Disease

Excess cortisol dysregulates carbohydrate, protein, and fat metabolism.

Persistent hyperglycemia contributes to insulin resistance.

Protein catabolism leads to muscle wasting and thinning of the skin.

Fat redistribution occurs, leading to central obesity and characteristic facial features.

Cardiovascular Effects

Cortisol elevates blood pressure by enhancing vascular sensitivity to catecholamines and suppressing nitric oxide production.

Immune Effects

Suppressed inflammatory responses increase susceptibility to infections.


Diagnosis

Diagnosing Cushing’s syndrome involves clinical assessment and laboratory confirmation of hypercortisolism.

Screening Tests

24-hour urinary free cortisol (UFC): Elevated levels confirm hypercortisolism.

Low-dose dexamethasone suppression test: Failure to suppress cortisol indicates Cushing’s syndrome.

Late-night salivary cortisol: Elevated levels are highly specific for hypercortisolism.

Differential Diagnosis

Measurement of ACTH helps differentiate ACTH-dependent from ACTH-independent causes.

Imaging studies (e.g., MRI of the pituitary, CT of the adrenal glands) localize the source.


Treatment Regimens

Treatment for Cushing’s syndrome depends on the underlying cause and aims to normalize cortisol levels.

Surgical Management

Transsphenoidal surgery: Preferred for ACTH-secreting pituitary adenomas.

Adrenalectomy: Indicated for adrenal adenomas or carcinomas.

Resection of ectopic ACTH-producing tumors: Essential for source control.

Medical Management

Steroidogenesis Inhibitors: Metyrapone, ketoconazole, or osilodrostat reduce cortisol production.

Pituitary-Directed Therapy: Pasireotide (a somatostatin analog) inhibits ACTH secretion.

Glucocorticoid Receptor Antagonists: Mifepristone is used in severe hyperglycemia cases.

Radiation Therapy

Used in cases of recurrent or persistent pituitary tumors after surgery.


Patient Education

Understanding the Disease

Educate patients about the cause and symptoms of Cushing’s syndrome.

Stress the importance of follow-up and adherence to prescribed treatments.

Managing Medication

Gradual tapering of corticosteroids prevents withdrawal and adrenal insufficiency.

Lifestyle Modifications

Encourage weight loss and regular physical activity to mitigate metabolic complications.

Stress reduction techniques may benefit patients with neuropsychiatric symptoms.

Support Systems

Provide resources for counseling and support groups to help cope with the emotional burden.


Additional Considerations

Complications

Cardiovascular disease, infections, and osteoporosis are common in untreated cases.

Long-term use of medications like ketoconazole requires monitoring for hepatotoxicity.

Prognosis

Early intervention improves outcomes, but untreated Cushing’s syndrome has a poor prognosis.


Conclusion

Cushing’s syndrome is a complex endocrine disorder requiring a multidisciplinary approach for diagnosis and treatment. Early recognition and management are critical to reduce morbidity and mortality associated with the condition. Continued research into targeted therapies offers hope for improving patient outcomes.


References

Bertagna, X., Guignat, L., Groussin, L., & Bertherat, J. (2009). Cushing’s disease. Best Practice & Research Clinical Endocrinology & Metabolism, 23(5), 607-623. https://www.sciencedirect.com/science/article/pii/S1521690X09000789

Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015). Cushing’s syndrome. The Lancet, 386(9996), 913-927. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)61375-1/fulltext

Nieman, L. K., Biller, B. M., Findling, J. W., Newell-Price, J., Savage, M. O., & Stewart, P. M. (2008). The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism, 93(5), 1526-1540. https://academic.oup.com/jcem/article/93/5/1526/2597367

National Institutes of Health. (2023). Cushing’s Syndrome. https://www.niddk.nih.gov/health-information/endocrine-diseases/cushings-syndrome

Mayo Clinic. (2023). Cushing syndrome. https://www.mayoclinic.org/diseases-conditions/cushing-syndrome/symptoms-causes/syc-20351310

 
Do you need a similar assignment done for you from scratch? Order now!
Use Discount Code "Newclient" for a 15% Discount!

Week 4: Skin Comprehensive SOAP Note

Week 4: Skin Comprehensive SOAP Note

Week 4

Skin Comprehensive SOAP Note

Patient Initials: D.W.              Age: 32                                   Gender: Female

SUBJECTIVE DATA:

Chief Complaint (CC) (Graphic 2): “I feel less confident around people, including my husband, and I cannot go out to swim or wear bikini or crop tops.”

History of Present Illness (HPI): D.W. is a 32-year-old single African American woman who is 29 weeks pregnant and presenting at the clinic with complaints of increasing stretch marks in the past one and a half months. D.W. claims that due to the stretch marks, she has lost confidence and self-esteem. She denies feeling any pain in places of the abdomen but explains that the area might be “itchy” and that the lines are continuing to darken. She claims that since she cannot wear a bikini, crop top, or swimsuit, she would like anything to reduce the stretch marks. She indicates 0/10 for reported pain on the pain scale and denies fever. Over-the-counter cocoa butter was ineffective in eliminating or reducing stretch marks. She also thinks her stretch marks are related to weight gain.

Medications:

  1. Prenatal Rx: 1 tablet daily
  2. Amlodipine for HTN: 10 mg daily
  3. Albuterol 90mcg for Asthma
  4. Cortisone OTC for itching skin: Applies at least 6 times daily

 

Allergies: Patient reports she is allergic to dust, mold, pollen, and metronidazole

Past Medical History (PMH): The patient developed HTN when she was 24, asthma at 4 years, although controlled, and allergic rhinitis at age 7. She also has past medical history of bacterial vaginosis, controlled with medication, and anxiety, which was managed without medication.

Past Surgical History (PSH): The patient underwent a surgical report of the umbilical hernia in 2006.

Sexual/Reproductive History: D.W. reports that she is married with one child, which she conceived at 26 years. This is her second pregnancy. She is sexually active and not on using condoms. She has one sexual partner, and together they go for regular testing for STIs, every four months.

Personal/Social History: She is married and currently lives with her husband. She has an extended family comprising of her mother and father and two brothers.

Health Maintenance:

  • She does not smoke
  • She maintains one sexual partner
  • Maintains a healthy diet, although she has experienced weight gain during pregnancy.
  • She maintains a healthy, supportive relationships with members of the extended family and friends.

Immunization History:

  1. Covid vaccination
  2. Influenza vaccine: 09/10/2019
  3. Tdap: 07/4/2020
  4. Measles and Rubella

Significant Family History: She has an extended family comprising of the mother, father and two brothers. Her grandparents are dead. The mother, 60, has a history of asthma and depression. The father, 63, has a history of diabetes. The brothers are 35 and 27 years and have no medical history.

Review of Systems:

General: The patient reports fatigue over the last two months. She denies fever, syncope, lightheadedness with standing or ambulation, or chills. She reports sleeping 7-10 hours a day. She reports pervasive weight gain over the course of her pregnancy, gaining about 10 pounds.

            HEENT

Respiratory: Patient reports a history of asthma. Denies history of pneumonia, dyspnea or hemoptysis. Reports dyspnea during vigorous physical activities like running or walking fast.

Cardiovascular/Peripheral Vascular: Denies chest pain, chest pressure, or chest discomfort. No palpitations or edema.

Gastrointestinal: The patient reports diet changes, feelings of nausea and vomiting. Denies diarrhea. No abdominal pain or blood. Patient reports experiencing constipation.

Genitourinary: Denies burning on urination, urgency, hesitancy, odor, odd color.

Musculoskeletal: The patient reports occasional muscle pain and weakness. Denies back pain and muscle or joint stiffness.

Neurological: Denies headaches, dizziness, syncope, paralysis, ataxia, numbness, or tingling in the extremities. No change in bowel or bladder control.

Psychiatric: Patient reports a history of anxiety, controlled nonmedically through meditation and physical exercise.

Skin/hair/nails: Patient indicates intermittent abdominal pruritus, scalp dandruff. Patient denies dermatitis on other body areas, spontaneous bruising, brittle hair, yellowing nails, or fungal infections. She reports itching, controlled using Cortisone OTC.  

OBJECTIVE DATA:

Physical Exam:

Vital signs: temp: 98.6F, B.P.: 100/65, P: 85, R.R.: 18, pain: 0/10 Ht: 5’5 feet, Wt.: 167 lbs., BMI: 27.8

General: Well-nourished and groomed AXOx4 32-year-old Black female, with appropriate mood, bright affect, and polite.

HEENT: Normocephalic and atraumatic. Sclera anicteric, No conjunctival erythema, PERRLA, oropharynx red, moist mucous membranes.

Neck: Supple. No JVD. Trachea midline. No pain, swelling, or palpable nodules.

Chest/Lungs: The patient’s heartbeat and rhythm are normal. The patient’s heart rate is within normal range, and capillaries refill within two seconds.

Heart/Peripheral Vascular: Regular rate and rhythm noted. No murmurs. No palpitation. No peripheral edema to palpation bilaterally.

Abdomen: Normal active bowel sounds x4. No rebound tenderness X 4. Soft abdomen. No organomegaly. Fundal distance 30cm

Genital/Rectal: D.W. decline, reporting seeing a gynecologist routinely.

Musculoskeletal: Normal range of motion. Low muscle mass for age. No signs of swelling or joint deformities. Muscle and back pain rated 0/10.

Neurological: Balance is stable, gait is normal, posture is erect, the tone is good, and speech is clear.

Skin: Multiple stretch marks visible on the abdomen; color nigrae and albae. Noted skin xerosis to the abdomen, linea nigra vertically from pubic bone to intermediary breast. No lymph nodes on palpation. Severe striae as indicated by TSS:> 18

Diagnostic results:

  1. HCT – 36
  2. WBC 5.89
  3. Albumin – 3.7
  4. Sodium – 135
  5. Potassium – 3.7
  6. AIC – 4.6
  7. Fibrinogen – 215
  8. Rh negative

ASSESSMENT:

Primary diagnosis:

  1. Striae gravidarum and Linea Nigra:

Stretch marks, or striae gravidarum, develop in roughly 50 to 90% of pregnant women as the uterus grows inside the abdominal cavity and separates the connective tissue beneath (Oakley & Patel, 2022). Early stretch marks are reddish-purple and develop as skin collagen is damaged and blood vessels enlarge. White or brown mature stretch marks result from melanocytes or pigment-producing cells dying due to collagen remodeling. Stretch marks most frequently appear on the breasts, thighs, and abdomen (Dai et al., 2021). A woman’s skin type and family history affect the thickness of the striae. The weight gain D.W. experienced could explain the striae gravidarum, the first confirmed diagnosis, vividly noticeable to her abdomen.

Linea is a brown line visible on the abdomen, running from the umbilical to the symphysis pubis. Usually, around the second or third trimester of pregnancy, linea nigra symptoms manifest. Linea nigra hyperpigmentation is brought on by hormonal fluctuations in progesterone and estrogen during pregnancy, which lead the cells to stimulate melanocytes in the skin more (Barnawi et al., 2021). The skin’s increased melanocyte count is what makes the abdomen darker. Linea nigra is also vividly noticeable on D.W. abdomen, confirming it as the second diagnosis.

Differential Diagnosis

  1. Linear Focal Elastosis: Uncertain etiology characterizes linear focal elastosis (LFE), an unusual benign acquired elastotic disease. Clinically, it is distinguished by several asymptomatic, raised, yellowish striae-like lines or bands dispersed horizontally throughout the lower and middle portion of the posterior trunk (Florell et al., 2017). The dermis’s focused increase in elastic fibers is the histological sign of LFE. The most common differential for LFE is Striae distensae.
  2. Steroid Induced Skin Atrophy: Topical steroids applied excessively on the skin might lead to steroid-induced skin atrophy. D.W.  exceeded the recommended dosage by using cortisone at least six times daily. Two to three times a day is recommended for using cortisone cream. When applied excessively, topical cortisone creams can lead to lipocortin production that blocks enzyme phospholipase A2, resulting in erythema and striae distensae (Niculet et al., 2020). Protein catabolism and increased mitotic activity caused the enzyme phospholipase to develop, which helps to reduce inflammation. As seen in striae distensae, the atrophy brought on by excessive topical steroid use can elevate the skin, create vasoconstriction, and cause itching.
  3. Cushing’s Syndrome: Cushing’s syndrome frequently presents as different skin disorders because of endogenous glucocorticoids and hypercortisolism. Although miscarriages are uncommon during pregnancy, they are highly likely when high blood pressure is present (Chaudhry & Singh, 2022). Striae distensae, a Cushing’s syndrome-related condition, results in dark, medium-sized to wide marks on the back, hips, thighs, and belly. Stretch marks are caused in patients with this illness by significant weight gain, high cortisol levels, and thin skin.
  4. Pruritic Urticarial and Plagues of Pregnancy (PUPPP): PUPPP can develop at the end of the second trimester and continue into the third trimester in places including the belly, legs, and forearms (Ishikawa-Nishimura et al., 2021). D.W.’s belly shows extensive striae, which she describes as itchy. Target lesions on the abdomen might appear in PUPPP patients as itchy, edematous eczema lesions resembling stretch marks or a combination of stretch marks and eczema. Owing to PUPPP’s pathophysiology, it frequently goes undetected and eludes treatment during pregnancy. In PUPPP, Th2 cytokines such as IL-9 and IL-33 are upregulated. These cytokines target body parts where there is an excess of cortisol and cause hyperpigmentation, skin eruptions, and patchy white lesions with stretch marks.

Week 4: Skin Comprehensive SOAP Note

PLAN: This section is not required for the assignments in this course (NURS 6512), but will be required for future courses.

 

References

Barnawi, A. M., Barnawi, G. M., & Alamri, A. M. (2021). Women’s Health: Most Common Physiologic and Pathologic Cutaneous Manifestations During Pregnancy. Cureus13(7), e16539. https://doi.org/10.7759/cureus.16539

Chaudhry, H. S., & Singh, G. (2022). Cushing syndrome. In StatPearls [Internet]. StatPearls Publishing.

Dai, H., Liu, Y., Zhu, Y., Yu, Y., & Meng, L. (2021). Study on the methodology of striae gravidarum severity evaluation. Biomedical engineering online20(1), 109. https://doi.org/10.1186/s12938-021-00945-w

Florell, A. J., Wada, D. A., & Hawkes, J. E. (2017). Linear focal elastosis associated with exercise. JAAD case reports3(1), 39–41. https://doi.org/10.1016/j.jdcr.2016.10.012

Ishikawa-Nishimura, M., Kondo, M., Matsushima, Y., Habe, K., & Yamanaka, K. (2021). A Case of Pruritic Urticarial Papules and Plaques of Pregnancy: Pathophysiology and Serum Cytokine Profile. Case reports in dermatology, 13(1), 18-22. https://doi.org/10.1159/000511494

Niculet, E., Bobeica, C., & Tatu, A. L. (2020). Glucocorticoid-Induced Skin Atrophy: The Old and the New. Clinical, cosmetic and investigational dermatology13, 1041–1050. https://doi.org/10.2147/CCID.S224211

Oakley, A.M., & Patel, B.C. (2022). Stretch Marks. In: StatPearls [Internet]. StatPearls Publishing.

 
Do you need a similar assignment done for you from scratch? Order now!
Use Discount Code "Newclient" for a 15% Discount!